Could J147 be the next breakthrough for stroke patients?
Disease control
Not yet recruiting
This study tests whether the drug J147, given by IV along with standard clot-removal therapy, helps people recover better after an ischemic stroke. About 196 participants will receive either J147 or a placebo, and researchers will track safety, brain scans, and functional outcome…
Phase: PHASE2 • Sponsor: Abrexa Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC